Opioid receptors are located throughout the central and peripheral nervous systems and interact with opiate drugs such as morphine to affect the perception of pain, consciousness, and autonomic function. Three types of opioid receptors, , ␦, and , have been defined and cloned (1, 2). These receptors belong to the superfamily of G-protein-coupled receptors and regulate a number of signaling pathways (3-8). The regulated pathways include the inhibition of adenylyl cyclase activity and N-type and L-type Ca 2ϩ channels and the activation of inwardly rectifying K ϩ channels. The activation of these opioid receptors also increases phospholipase C activity and causes a transient increase in the activation of the mitogen-activated protein kinase (MAPK), 1 ERK1, and ERK2-2 (9 -11). The expression of opioid receptors has been examined primarily by in situ hybridization, immunohistochemistry, and ligand binding assays (12-15).The mouse -opioid receptor (KOR) gene has been isolated in several laboratories (16). The genetic basis underlying the ontogenesis of KOR gene has been revealed in transgenic animal models in our laboratory (17). The mouse gene contains four exons and utilizes two promoters. A total of three KOR mRNA isoforms designated as a, b, and c can be generated (18). We have previously reported the activities of dual promoters of mouse KOR gene in the P19 cell line (19). Recently, we have demonstrated the up-regulation of the endogenous KOR mRNA by depleting vitamin A in developing animals and the downregulation of KOR mRNA in differentiating P19 cells treated with retinoic acid (RA) for 2 days or longer. This is mediated by a negative regulatory element, which contains an Ikaros binding site within intron I (promoter II) of the KOR gene (20, 21).Interestingly, a short term (within 24 h) treatment with RA induces KOR expression in P19. We now report the mechanism mediating the early inducing effect of RA on KOR gene expression in P19 cells. We first identified a cis-acting element containing a putative Sp1 binding site (GC box) in the promoter I of the mouse KOR gene. We then demonstrated that Sp1 could bind to this GC box, and the hypophosphorylation of Sp1 enhanced its DNA binding affinity to this element. The inhibition of ERKs pathway enhanced RA induction of this promoter activity, whereas the phosphatase inhibitor suppressed RA induction of this promoter. These results demonstrated that RA-induced KOR gene expression could be mediated by the enhanced binding of Sp1 to this promoter, a consequence of hypophosphorylation of Sp1 by blocking the ERK pathway.
EXPERIMENTAL PROCEDURESPlasmid Constructs-Luciferase fusion plasmids were constructed by inserting various upstream regulatory sequences into a promoterless and enhancerless luciferase vector pGL3B (Promega, Madison, WI). The K45 and K19 plasmids were constructed as described previously (21). K45 contains a KOR-genomic fragment of 1320 bp from the BamHI site to the ATG codon. K19 was a truncation of K45 that contains a 904-bp KOR-genomic fragment from Bam...